Search clinical trials for: Ibrutinib and Bortezomib R-CHOP
Total 2857 results
-
Assistance Publique - Hôpitaux de ParisCompletedHealthy VolunteersFrance
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedColorectal CancerCanada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and...TerminatedMyelodysplastic SyndromeUnited States
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic Lymphoma GroupActive, not recruiting
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia With 17p Deletion | Small Lymphocytic Lymphoma With 17p DeletionUnited States, United Kingdom, Belgium, Germany, Turkey, Australia, Canada, New Zealand, Sweden
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
European Organisation for Research and Treatment...CompletedMalignant MesotheliomaUnited Kingdom
-
OncotherapeuticsMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Blastic Phase Chronic Myelogenous Leukemia and other conditionsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMantle Cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedDiffuse, Large B-Cell, LymphomaChina
-
University of Kansas Medical CenterMillennium Pharmaceuticals, Inc.CompletedAutologous Transplant | Malignant Lymphoma, Stem Cell TypeUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
Sinocelltech Ltd.Unknown
-
Peter MacCallum Cancer Centre, AustraliaNovartisActive, not recruitingMantle Cell Lymphoma RecurrentAustralia
-
Massachusetts General HospitalM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Dana-Farber...CompletedNon Small Cell Lung CancerUnited States
-
Scios, Inc.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pharmacyclics LLC.Completed
-
Pharmacyclics LLC.CompletedGraft Versus Host DiseaseUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
Cancer Trials IrelandCompletedMalignant MesotheliomaUnited Kingdom, Ireland, Belgium, Netherlands
-
University of BolognaJanssen-Cilag Ltd.Unknown
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.TerminatedHigh Risk Smoldering Multiple MyelomaUnited States
-
Scios, Inc.Completed
-
Virginia Commonwealth UniversityCompletedMelanoma | Soft Tissue Sarcoma | Parathyroid Carcinoma | Small Cell Carcinoma of the Lung | Carcinoid TumorsUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedWaldenstrom MacroglobulinemiaFrance
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, United Kingdom, Canada, Israel, France, Austria, Belgium, Germany, Ireland, Italy, Netherlands, Spain, Sweden
-
Christian BuskeAmgen; Janssen, LPRecruitingWaldenstrom MacroglobulinemiaAustria, Germany, Greece
-
Novartis PharmaceuticalsTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyWithdrawnWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia
-
Endomagnetics Ltd.Recruiting
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Sun Yat-sen... and other collaboratorsRecruitingFollicular Lymphoma | DLBCL - Diffuse Large B Cell LymphomaChina
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
National Cancer Institute (NCI)CompletedSquamous Cell CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral... and other conditionsUnited States